North America holds a significant share of the Gel Column Agglutination Test System Market, supported by a strong healthcare system, growing blood donation and transfusion activities, and increasing adoption of advanced diagnostic solutions. Rising investments in laboratory automation, stringent transfusion safety standards, and ongoing technological advancements continue to drive market growth...